News related to Afinitor (Everolimus) and/or conditions it is approved for
FDA OKs New Kids' Dose of Cancer Drug
Source: MedPage Today Product Alert [2012.08.30]
WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.
Sunitinib or Everolimus First-Line for Kidney Cancer?
Source: Medscape Hematology-Oncology Headlines [2014.07.24]
A phase 2 randomized comparator trial has found that first-line everolimus is not as effective as first-line sunitinib, and has a different toxicity profile.
Medscape Medical News
Drug everolimus does not improve overall survival in patients with advanced liver cancer
Source: Liver Disease / Hepatitis News From Medical News Today [2014.07.03]
Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study in JAMA.